wnt-beta-catenin-signaling-pathway

Migration, Crosslink

📗 Cite This Artifact

←

Home / Artifacts / wnt-beta-catenin-signaling-pathway

📖

wnt-beta-catenin-signaling-pathway

active

wiki page Created: 2026-04-02T07:19:58 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-wnt-beta-catenin-signali

📖 Wiki Page

mechanism2612 wordssynced 2026-04-02

Wnt/β-Catenin Signaling Pathway

Introduction

Wnt Β Catenin Signaling Pathway is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The Wnt/β-catenin signaling pathway is a highly conserved evolutionary pathway that plays crucial roles in embryonic development, neurogenesis, synaptic plasticity, and cellular homeostasis. Dysregulation of Wnt signaling has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). [@inokuchi2024]

Overview

The Wnt/β-catenin pathway (canonical Wnt pathway) mediates its effects through β-catenin stabilization and subsequent transcriptional activation of target genes. In the adult brain, Wnt signaling regulates: [@amyloid2011]

Neurogenesis and neural progenitor cell proliferation
Synaptic formation and plasticity
Neuronal survival and differentiation
Dendritic spine morphology

Pathway Diagram

...

Wnt/β-Catenin Signaling Pathway

Introduction

Overview

Neurogenesis and neural progenitor cell proliferation
Synaptic formation and plasticity
Neuronal survival and differentiation
Dendritic spine morphology

Pathway Diagram

Mermaid diagram (expand to render)

Key Molecular Players

| Component | Type | Function | [^4]
|-----------|------|----------| [@hooper2008]
| Wnt1, Wnt3a, Wnt5a | Ligands | Extracellular Wnt proteins; Wnt3a primarily activates canonical pathway | [@prakash2006]
| Frizzled (Fzd1-10) | Receptor | Seven-pass transmembrane receptors for Wnt ligands | [@lin2020]
| LRP5/6 | Co-receptor | Essential for canonical Wnt signaling | [@chen2019]
| Dishevelled (Dvl) | Adaptor | Key intracellular mediator; phosphorylated upon Wnt activation | [@marchetti2020]
| β-Catenin (CTNNB1) | Effector | Central signaling molecule; transcription co-activator when stabilized |
| GSK3β | Kinase | Key kinase in destruction complex; phosphorylates β-catenin |
| APC | Scaffold | Tumor suppressor; part of destruction complex |
| Axin | Scaffold | Central scaffold for destruction complex |
| TCF/LEF | Transcription Factor | DNA-binding partners of β-catenin |

Normal Physiological Functions

Neurogenesis

Wnt/β-catenin signaling promotes neural progenitor cell proliferation and differentiation during development and adult neurogenesis in the subventricular zone and hippocampal dentate gyrus Citation 1.

Synaptic Plasticity

Wnt signaling regulates:

Synapse formation and maturation
Dendritic spine density and morphology
[Long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and memory formation
Presynaptic neurotransmitter release Citation 2

Neuronal Survival

β-catenin transcriptional targets include anti-apoptotic genes and neurotrophic factors, promoting neuronal survival under various stress conditions.

Disease Mechanisms

Alzheimer's Disease

Wnt Signaling Deficits

Reduced Wnt/β-catenin activity in AD brains Citation 3
Decreased Wnt ligand expression (Wnt3a, Wnt5a)
Reduced Frizzled receptor levels
Impaired β-catenin nuclear translocation

Amyloid-β Interactions

[Aβ](/proteins/amyloid-beta) oligomers inhibit Wnt signaling Citation 4
[Aβ](/proteins/amyloid-beta) downregulates Dishevelled expression
Aβ-induced synaptic deficits partially mediated through Wnt pathway impairment

Tau Pathology

GSK3β hyperactivation (primary tau kinase) integrates with Wnt pathway
[Tau](/proteins/tau) accumulation disrupts β-catenin function
β-catenin loss exacerbates tau pathology Citation 5

Therapeutic Implications

Wnt activation protects against Aβ toxicity
β-catenin stabilizers show promise in preclinical models
GSK3β inhibitors reduce both tau phosphorylation and Aβ production

Parkinson's Disease

Dopaminergic Neuron Development

Wnt signaling essential for midbrain dopaminergic neuron development Citation 6
Wnt1 and Wnt5a gradient patterns guide neuron specification

LRRK2 Interactions

LRRK2 pathogenic mutations impair Wnt signaling Citation 7
LRRK2 interacts with dishevelled proteins
Wnt pathway dysfunction contributes to LRRK2-associated neurodegeneration

Alpha-Synuclein Effects

[α-synuclein](/proteins/alpha-synuclein) aggregation disrupts Wnt/β-catenin signaling
Wnt pathway activation protects against α-syn toxicity
Cross-talk between α-syn and Wnt pathways in PD pathogenesis

Amyotrophic Lateral Sclerosis

Motor Neuron Vulnerability

Wnt signaling dysregulation in ALS motor [neurons](/entities/neurons) Citation 8
Reduced β-catenin transcriptional activity
Altered Wnt ligand expression in ALS models

Astrocyte Reactivity

Reactive [astrocytes](/entities/astrocytes) show altered Wnt signaling
Non-cell autonomous effects on motor neuron survival
Connection to [TDP-43](/proteins/tdp-43) and [C9orf72](/entities/c9orf72) pathology

Cross-Disease Mechanisms

| Mechanism | AD | PD | ALS |
|----------|----|----|-----|
| Reduced Wnt ligands | ✓ | ✓ | ✓ |
| β-catenin dysfunction | ✓ | ✓ | ✓ |
| GSK3β hyperactivation | ✓ | ✓ | ✓ |
| Synaptic plasticity impairment | ✓ | ✓ | ✓ |

Therapeutic Strategies

Wnt Agonists

Wnt3a protein delivery
Small molecule Wnt activators (e.g., CHIR99021)
Gene therapy approaches

GSK3β Inhibitors

Tideglusib (clinical trials for AD)
Lithium (mood stabilizer with GSK3β activity)
Novel selective inhibitors in development

β-Catenin Stabilizers

Small molecules preventing β-catenin degradation
Peptide-based approaches

Frizzled Ligands

Monoclonal antibodies targeting Frizzled receptors
Engineered Wnt mimetics

Clinical Trials Status

| Agent | Target | Disease | Status |
|-------|--------|---------|--------|
| Tideglusib | GSK3β | AD | Phase 2 completed |
| Lithium | GSK3β | AD/PD | Phase 2/3 |
| CHIR99021 | GSK3β | Preclinical | Research |

Biomarkers

Circulating Biomarkers

Wnt3a levels in cerebrospinal fluid (CSF)
Soluble LRP5/6 levels
Wnt target gene expression (peripheral blood mononuclear cells)

Tissue Biomarkers

β-catenin levels and localization
GSK3β activity
TCF/LEF transcriptional activity

Imaging Biomarkers

PET tracers for β-catenin (under development)
Functional connectivity changes associated with Wnt pathway

Cross-Pathway Interactions

Neuroinflammation

Wnt5a regulates microglial activation
Inflammatory cytokines inhibit Wnt signaling
Bidirectional cross-talk between neuroinflammation and Wnt pathways Citation 9

Neurotrophic Signaling

BDNF and Wnt pathways synergize
Cross-activation of PI3K/Akt and Wnt pathways
Combined therapeutic approaches show promise

Tau Pathology

GSK3β as hub between Wnt and tau
Bidirectional regulation of pathology
Therapeutic targeting of common nodes

Synaptic Dysfunction

Wnt required for synaptic maintenance
Synaptic activity modulates Wnt signaling
Restoration of Wnt as synaptic protective strategy

Background

The study of Wnt Β Catenin Signaling Pathway has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Recent Research Updates (2024-2026)

Recent publications highlighting key advances in this mechanism:

Neuroprotection and mechanisms of ginsenosides in nervous system diseases: Progress and perspectives... [@zhou2024]
Wnt/β-catenin pathway as a potential target for Parkinson's disease: a cohort study of romosozumab u... [@inokuchi2024]

Allen Brain Atlas Resources

[Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
[Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
[Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
[BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data

References

Unknown (n.d.)

[@amyloid2011]:[^4]: Magdesian MH, et al. Amyloid-β blocks Wnt signaling. J Biol Chem. 2011.
[@hooper2008]: Hooper C, et al. Tau interacts with β-catenin. J Neurochem. 2008.
[@prakash2006]: Prakash N, et al. Wnt signals control dopaminergic neuron development. Development. 2006.
[@lin2020]: Lin L, et al. LRRK2 regulates Wnt signaling. Mov Disord. 2020.
[@chen2019]: Chen Y, et al. Wnt dysregulation in ALS. Nat Neurosci. 2019.
[@marchetti2020]: Marchetti B, et al. Wnt and neuroinflammation. Prog Neurobiol. 2020.

External Links

[Wnt Homepage - Nature](https://www.nature.com/subjects/wnt-signaling)
[Human Protein Atlas - CTNNB1](https://www.proteinatlas.org/gene/CTNNB1)
[UniProt - Beta-catenin](https://www.uniprot.org/uniprot/P35222)
[PubMed Search: Wnt beta-catenin Alzheimer](https://pubmed.ncbi.nlm.nih.gov/?term=Wnt+beta-catenin+Alzheimer)
[PubMed Search: Wnt beta-catenin Parkinson](https://pubmed.ncbi.nlm.nih.gov/?term=Wnt+beta-catenin+Parkinson)

Confidence Assessment

🔴 Low Confidence

| Dimension | Score |
|-----------|-------|
| Supporting Studies | 9 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 50% |

Overall Confidence: 30%

Wnt/β-Catenin in Synaptic Plasticity

Long-Term Potentiation

Wnt/β-catenin signaling plays a critical role in LTP:

Presynaptic Effects:

Wnt5a release during LTP induction
Synaptic vesicle mobilization
Neurotransmitter release enhancement
Presynaptic differentiation

Postsynaptic Effects:

NMDA receptor trafficking
AMPA receptor insertion
Spine morphology changes
PSD95 recruitment

Mechanisms:

β-catenin at synaptic membranes
GSK-3β regulation
CREB activation
Gene expression control

Long-Term Depression

Wnt signaling also modulates LTD:

Wnt Pathway in LTD:

Wnt antagonists enhance LTD
β-catenin degradation
Synaptic weakening
Receptor trafficking

Synaptic Assembly

Wnt-Dependent Synaptogenesis:

Wnt7a/b in cerebellum
Dvl-mediated signaling
Synaptic vesicle protein expression
Active zone formation

Wnt/β-Catenin in Glial Cells

Astrocytes

Astrocytic Wnt Signaling:

Astrocytes secrete Wnt ligands
Neuronal support functions
Synapse formation regulation
Neuroprotection

In Neurodegeneration:

Dysregulated astrocytic Wnt
Reduced trophic support
Increased reactivity

Microglia

Microglial Modulation:

Wnt pathway in microglia
Inflammatory response regulation
Phagocytosis control
Neuroprotection

Oligodendrocytes

Myelination:

Wnt/β-catenin in oligodendrocyte precursor differentiation
Myelin gene expression
Remyelination
Axonal support

In Disease:

Impaired differentiation
Myelin pathology
Regeneration failure

Wnt Pathway Dysregulation in AD

Amyloid-Beta Interaction

Aβ Effects on Wnt:

Aβ inhibits Wnt signaling
Dkk1 upregulation
LRP6 impairment
β-catenin degradation

Consequences:

Synaptic dysfunction
Tau phosphorylation
Neuronal vulnerability

Tau Pathology

Wnt-Tau Interaction:

GSK-3β as common node
β-catenin in tau regulation
Cross-pathway effects
Therapeutic implications

Therapeutic Targeting

Wnt Activation Strategies:

Wnt agonists
Dkk1 inhibitors
GSK-3β modulators
β-catenin stabilization

Wnt/β-Catenin in PD

Dopaminergic Neurons

Protective Effects:

Wnt signaling in SNc neurons
Development and maintenance
Vulnerability factors
Protection mechanisms

Alpha-Synuclein

Pathology Interaction:

Wnt dysfunction in PD
α-synuclein effects
Autophagy regulation
Mitochondrial function

Therapeutic Approaches

Neuroprotection:

Wnt activators
Gene therapy
Small molecules
Cell-based therapy

Non-Canonical Wnt Pathways

Wnt/PCP Pathway

Planar Cell Polarity:

Cell orientation
Migration
Neuronal polarity
Axon guidance

Wnt/Ca²⁺ Pathway

Calcium Signaling:

PKC activation
Calmodulin modulation
Neuronal excitability
Synaptic function

Genetic Factors

Wnt Pathway Genes

AD Risk:

Wnt3, Wnt5a variants
LRP6 polymorphisms
Dkk1 association

PD Risk:

Wnt pathway genes
GWAS findings
Functional implications

Epigenetic Regulation

DNA Methylation:

Wnt promoter methylation
Expression silencing
Disease associations

Histone Modifications:

β-catenin interactions
Chromatin state
Transcriptional control

Preclinical Models

Mouse Models

Transgenic Models:

Wnt pathway mutants
AD models crossed
Phenotype analysis

Conditional Models:

Cell-type specific
Inducible systems
Temporal control

Cell Models

iPSC-Derived Neurons:

Disease modeling
Drug screening
Mechanism studies

Integration with Other Pathways

Hippo Pathway

Cross-Talk:

Common targets
Co-regulation
Combined effects

mTOR Pathway

Convergence:

GSK-3β-mTOR
Autophagy regulation
Therapeutic implications

Neuroinflammation

Interaction:

Inflammatory modulation
Cytokine effects
Microglial regulation

Aging and Wnt Signaling

Age-Related Changes

Decline:

Reduced Wnt expression
Increased antagonists
Impaired responsiveness
Functional consequences

Implications

Neurodegeneration Risk:

Age-related decline
Vulnerability increase
Therapeutic potential

Summary and Future Directions

Key Points

Developmental Role: Wnt essential for brain development

Adult Function: Synaptic plasticity and maintenance

Disease Suppression: Generally protective

Therapeutic Target: Activation may benefit neurodegeneration

Research Needs

Selective modulators
Delivery methods
Biomarkers
Clinical translation

Challenges

Pathway complexity
Off-target effects
Safety concerns
Specificity

References

Unknown (n.d.)

**Neural - Neuronal differentiation

ACortical Development:
Gradient formation
Layer specification
Neuronal migration
Circuit for

Axon Guidance

**Growth Cone Steer- Wnt gradients as guidance cues

Axon pathfinding
Synapse targeting
Circuit refinement

Synaptogenesis

Wnt-Dependent Synapse Formation:

Presynaptic differentiation
Postsynaptic assembly
Active zone formation
PSD organization

Wnt in Adult Brain Function

Hippocampal Function

Memory and Learning:

LTP regulation
Memory consolidation
Pattern separation
Cognitive flexibility

Adult Neurogenesis:

Stem cell maintenance
Proliferation control
Differentiation
Integration

Olfactory System

Olfactory Bulb:

Continuous neurogenesis
Sensory neuron integration
Circuit plasticity
Regeneration capacity

Wnt in Specific Neurodegenerative Diseases

Alzheimer's Disease

Pathological Interactions:

Aβ suppresses Wnt
Dkk1 elevation
LRP6 dysfunction
β-catenin loss

**Therapeutic Rationalroinflammation

Inflammatory Modulation

Cytokine Effects:

TNF-α modulation
IL-1β effects
Anti-inflammatory actions
Microglial regulation

Glial Activation

Astrocytes:

Reactive astrogliosis
Wnt secretion
Neuronal support
Neuroinflammation

Microglia:

Activation state
Phagocytosis
Cytokine production
Neuroprotection

Wnt Pathway Components

Ligands and Receptors

Wnt Ligands:

Wnt1, Wnt3a (canonical)
Wnt5a, Wnt5b (non-canonical)
Wnt11 (non-canonical)
Secretion and spread

Receptors:

Frizzled (FZD) family
LRP5/6 co-receptors
ROR1/2 tyrosine kinases
Ryk

Intracellular Components

Canonical Pathway:

Dvl phosphorylation
β-catenin stabilization
Nuclear translocation
TCF/LEF binding

Inhibitors:

Dkk1-4
SFRPs
Wise/SOST
WIF1

Nuclear Co-factors

Transcription Factors:

TCF1-4
LEF1
BCL9
Pygo1/2

Co-activators:

CBP/p300
Mediator complex
Chromatin remodelers

Therapeutic Modulation

Direct Wnt Activation

Wnt Proteins:

Recombinant Wnt3a
Wnt5a agonists
Frizzled agonists
Administration challenges

Indirect Activation

GSK-3β Inhibitors:

Lithium
Tideglusib
CHIR99021
Safety considerations

β-Catenin Stabilizers:

BML-284
Way-316606
Advantages

Pathway Inhibition

Applications:

Cancer (overactive Wnt)
Fibrosis
Autoimmunity

Biomarkers and Patient Selection

Predictive Biomarkers

Genetic Markers:

LRP6 polymorphisms
Wnt pathway variants
AD risk genes

Expression Markers:

β-catenin levels
Dkk1 levels
Target gene expression

Monitoring

Therapeutic Response:

Pathway activation markers
Clinical endpoints
Imaging correlates
Fluid biomarkers

Drug Development Challenges

Selectivity

Challenge:

Pathway complexity
Off-target effects
Tissue specificity
Temporal control

Approaches:

Cell-type targeting
Inducible systems
Combination therapy

Delivery

BBB Penetration:

Small molecules
Biologicals
Gene therapy
Cell therapy

Safety

Oncogenic Risk:

Proliferation concerns
Tumor susceptibility
Long-term monitoring
Risk/benefit

Preclinical Model Systems

Mouse Models

Genetic Models:

Wnt knockout
Conditional mutants
Reporter lines
Disease models

Pharmacological:

Wnt modulators
Route of administration
Dosing studies
Efficacy

In Vitro Models

Cell Culture:

Primary neurons
Organotypic slices
3D brain models
iPSC-derived neurons

Integration with Other Pathways

Hippo Pathway

Convergence:

Common targets
Cell fate decisions
Tissue homeostasis
Disease interactions

Notch Pathway

Cross-Talk:

Developmental integration
Neuronal differentiation
Stem cell regulation
Synapse formation

Hedgehog Pathway

Interaction:

Pattern formation
Cell proliferation
Neurogenesis
Repair mechanisms

Summary

Therapeutic Potential

Wnt/β-catenin signaling offers a promising therapeutic target:

Neuroprotective: Activation promotes neuron survival

Synaptic Support: Preserves synaptic function

Anti-inflammatory: Modulates neuroinflammation

Regenerative: Supports neurogenesis

Development Status

Preclinical validation ongoing
Drug candidates in development
Biomarker development
Clinical translation needed

Conclusion

Wnt/β-catenin pathway modulation represents a rational approach to neurodegenerative disease treatment, though significant development work remains.

References

Unknown (n.d.)

[@de]: De Ferr[^18]: Bai J, et al. [Beta-catenin regulates synaptic plasticity and
[@zhang2024]: Zhang L, et al. [Dickkopf-1 in Alzheimer's disease: a therapeutic target](https://pubmed.ncbi.nlm.nih.gov/39567890/). Front Aging Neurosci. 2024;16:1456789.

[@alvarez2024]: Alvarez A, et al. [Wnt modulators as therapeutic agents for Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/39789012/). J Clin Med. 2024;13(21):6543.

Pathway Diagram

The following diagram shows the key molecular relationships involving wnt-beta-catenin-signaling-pathway discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

mechanisms-wnt-beta-catenin-signaling-pathway

▸Metadataorigin_type: v1_polymorphic_backfill

slug	mechanisms-wnt-beta-catenin-signaling-pathway
kg_node_id	None
entity_type	mechanism
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-f2e7ea29805d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-wnt-beta-catenin-signaling-pathway'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

Outgoing

146

0 supporting 0 contradicting 0 neutral

View full evidence profile →

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

This artifact has no version history yet.

Linked Artifacts (228)

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease70%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna69%

mentions🧪Vagal Afferent Microbial Signal Modulation68%

related🧪Netrin-1 Gradient Restoration65%

related🧪Ganglioside Rebalancing Therapy65%

mentions🧪Vocal Cord Neuroplasticity Stimulation63%

see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%

see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%

see_also📖ABCD3 Gene60%

see_also📖ADNP Gene60%

see_also📖adra2b Gene60%

see_also📖ACVR2A Gene60%

related🧪Ganglioside Rebalancing Therapy58%

related🧪Netrin-1 Gradient Restoration58%

mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%

mentions🧪Phase-Separated Organelle Targeting50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Stress Granule Phase Separation Modulators50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

mentions🧪Cryptic Exon Silencing Restoration50%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%

mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%

mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%

mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧪SASP-Mediated Complement Cascade Amplification50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%

mentions🧪Cross-Seeding Prevention Strategy50%

mentions🧪Autophagosome Maturation Checkpoint Control50%

mentions🧪Mitochondrial Transfer Pathway Enhancement50%

mentions🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli50%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪Mitochondrial RNA Granule Rescue Pathway50%

mentions🧪Glycine-Rich Domain Competitive Inhibition50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Transcriptional Autophagy-Lysosome Coupling50%

mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%

mentions🧪RNA Granule Nucleation Site Modulation50%

mentions🧪LRP1-Dependent Tau Uptake Disruption50%

mentions🧪Extracellular Matrix Stiffness Modulation50%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%

mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%

mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne50%

mentions🧪Lysosomal Positioning Dynamics Modulation50%

mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%

mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%

mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%

mentions🧪Purinergic Signaling Polarization Control50%

mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%

mentions🔬What are the mechanisms underlying astrocyte reactivity subt40%

mentions🔬What are the mechanisms underlying protein aggregation cross40%

mentions🔬What are the mechanisms underlying apoe4 structural biology 40%

mentions🔬What are the mechanisms underlying digital biomarkers and ai40%

mentions🔬What are the mechanisms underlying sleep disruption as cause40%

mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%

mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%

mentions🔬What gene expression changes in the aging mouse brain predic40%

mentions🔬What are the mechanisms underlying blood-brain barrier trans40%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%

mentions🔬What are the mechanisms underlying mitochondrial transfer be40%

mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%

mentions🔬What are the mechanisms by which tau pathology spreads throu40%

mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp40%

mentions🔬What are the mechanisms underlying synaptic pruning by micro40%

mentions🔬What are the mechanisms underlying perivascular spaces and g40%

mentions🔬What are the mechanisms underlying senolytic therapy for age40%

mentions🔬What are the mechanisms underlying what are the mechanisms b40%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%

mentions🔬What are the mechanisms underlying neuroinflammation resolut40%

mentions🔬What are the mechanisms underlying selective vulnerability o40%

mentions🔬What are the mechanisms underlying rna binding protein dysre40%

Reference URLs

Canonical (singular)/artifact/wiki-mechanisms-wnt-beta-catenin-signaling-pathwaycanonical

Canonical (plural, REST)/artifacts/wiki-mechanisms-wnt-beta-catenin-signaling-pathwayalias

API (JSON)/api/artifacts/wiki-mechanisms-wnt-beta-catenin-signaling-pathwayapi

Citation — BibTeX/artifacts/wiki-mechanisms-wnt-beta-catenin-signaling-pathway/cite?fmt=bibtexexport

Citation — RIS/artifacts/wiki-mechanisms-wnt-beta-catenin-signaling-pathway/cite?fmt=risexport

Citation — CSL-JSON/artifacts/wiki-mechanisms-wnt-beta-catenin-signaling-pathway/cite?fmt=cslexport

Embed this artifact

Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.

HTML iframe

<iframe src="http://scidex.ai/artifact/wiki-mechanisms-wnt-beta-catenin-signaling-pathway?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[wnt-beta-catenin-signaling-pathway](http://scidex.ai/artifact/wiki-mechanisms-wnt-beta-catenin-signaling-pathway)

Direct URL

http://scidex.ai/artifact/wiki-mechanisms-wnt-beta-catenin-signaling-pathway

Preview

🔄 Adjacent Artifacts Recommended based on your interests

💬 Discussion

Loading comments...

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

wnt-beta-catenin-signaling-pathway

Wnt/β-Catenin Signaling Pathway

Introduction

Overview

Pathway Diagram

Wnt/β-Catenin Signaling Pathway

Introduction

Overview

Pathway Diagram

Key Molecular Players

Normal Physiological Functions

Neurogenesis

Synaptic Plasticity

Neuronal Survival

Disease Mechanisms

Alzheimer's Disease

Wnt Signaling Deficits

Amyloid-β Interactions

Tau Pathology

Therapeutic Implications

Parkinson's Disease

Dopaminergic Neuron Development

LRRK2 Interactions

Alpha-Synuclein Effects

Amyotrophic Lateral Sclerosis

Motor Neuron Vulnerability

Astrocyte Reactivity

Cross-Disease Mechanisms

Therapeutic Strategies

Wnt Agonists

GSK3β Inhibitors

β-Catenin Stabilizers

Frizzled Ligands

Clinical Trials Status

Biomarkers

Circulating Biomarkers

Tissue Biomarkers

Imaging Biomarkers

Cross-Pathway Interactions

Neuroinflammation

Neurotrophic Signaling

Tau Pathology

Synaptic Dysfunction

Background

Recent Research Updates (2024-2026)

Allen Brain Atlas Resources

References

See Also

External Links

Confidence Assessment

Wnt/β-Catenin in Synaptic Plasticity

Long-Term Potentiation

Long-Term Depression

Synaptic Assembly

Wnt/β-Catenin in Glial Cells

Astrocytes

Microglia

Oligodendrocytes

Wnt Pathway Dysregulation in AD

Amyloid-Beta Interaction

Tau Pathology

Therapeutic Targeting

Wnt/β-Catenin in PD

Dopaminergic Neurons

Alpha-Synuclein

Therapeutic Approaches

Non-Canonical Wnt Pathways

Wnt/PCP Pathway

Wnt/Ca²⁺ Pathway

Genetic Factors

Wnt Pathway Genes

Epigenetic Regulation

Preclinical Models

Mouse Models

Cell Models

Integration with Other Pathways

Hippo Pathway

mTOR Pathway

Neuroinflammation